RecruitingNCT04402086

Rheumatology Patient Registry and Biorepository

Sponsor

Yale University

Enrollment

5,000 participants

Start Date

Aug 4, 2020

Study Type

OBSERVATIONAL

Summary

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Min Age: 18 YearsMax Age: 99 Years

Patients ≥18 years old with a diagnosis of a rheumatic autoimmune disease including, but not limited to: adult onset Still's disease, ankylosing spondylitis, antiphospholipid syndrome, Behcet's disease, dermatomyositis, giant cell arteritis, mixed connective tissue disease, polymyalgia rheumatica, polymyositis, psoriatic arthritis, reactive arthritis, rheumatoid arthritis, sarcoidosis, scleroderma, Sjogren's syndrome, systemic lupus erythematosus, undifferentiated connective tissue disease and vasculitis.
Receiving clinical care at Yale Rheumatology clinics
Age ≥ 18 years old
No chronic skin conditions
No diagnosis of a rheumatic autoimmune disease (e.g., lupus, rheumatoid arthritis)
Normal BMI

Unable to provide informed consent
No patients will be excluded based on gender or ethnicity or pregnancy status.
Women who are currently pregnant will need to wait to donate a skin biopsy until after they deliver.
Patients allergic to lidocaine or epinephrine or have a history of impaired wound healing will not be able to donate a skin biopsy.
Unable to provide informed consent.
Currently pregnant or nursing unless the study goal is to study pregnant or nursing woman.
Allergies to lidocaine or epinephrine (skin biopsies).
A history of impaired wound healing (skin biopsies).

Yale New Haven Hospital

New Haven, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT04402086